These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1520018)
1. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system. Stanhope R; Albanese A; Moyle L; Hamill G Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a pen injector system for growth hormone treatment. Gluckman PD; Cutfield WS Arch Dis Child; 1991 Jun; 66(6):686-8. PubMed ID: 2053787 [TBL] [Abstract][Full Text] [Related]
3. Patient evaluation of a new injection pen for growth hormone treatment in children and adults. Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072 [TBL] [Abstract][Full Text] [Related]
4. Genotropin 16 IU KabiVial is more convenient than conventional administration systems for children on growth hormone therapy. Danielson K; Neumeyer L; Ritzén M Acta Paediatr Scand Suppl; 1990; 370():208-11. PubMed ID: 2260453 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone therapy with a new delivery system. Jørgensen JT; Susgaard S Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374 [TBL] [Abstract][Full Text] [Related]
6. Simplified growth hormone therapy--first clinical experience with the KabiPen. Albertsson-Wikland K Acta Paediatr Scand Suppl; 1988; 343():103-6. PubMed ID: 3057801 [TBL] [Abstract][Full Text] [Related]
7. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device. Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453 [TBL] [Abstract][Full Text] [Related]
8. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy. Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone administration by means of an injection pen. Jørgensen JO; Møller J; Jensen FS; Jørgensen JT; Christiansen JS Pharmacol Toxicol; 1989 Aug; 65(2):96-9. PubMed ID: 2813289 [TBL] [Abstract][Full Text] [Related]
10. Patient acceptance of Nordiject: a new drug delivery system for growth hormone. Jørgensen JT; Mortensen HB; Jørgensen JO DICP; 1991 Jun; 25(6):585-8. PubMed ID: 1877265 [TBL] [Abstract][Full Text] [Related]
11. Bacterial contamination of growth hormone solution and injection equipment during use by growth hormone deficient children. Zweens MJ; Drayer NM; Dankert J J Hosp Infect; 1991 Jun; 18(2):123-30. PubMed ID: 1678757 [TBL] [Abstract][Full Text] [Related]
12. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test. Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030 [TBL] [Abstract][Full Text] [Related]
13. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial. McAllister L; Anderson J; Werth K; Cho I; Copeland K; Le Cam Bouveret N; Plant D; Mendelman PM; Cobb DK Lancet; 2014 Aug; 384(9944):674-81. PubMed ID: 24881803 [TBL] [Abstract][Full Text] [Related]
14. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799 [TBL] [Abstract][Full Text] [Related]
15. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads. Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739 [TBL] [Abstract][Full Text] [Related]
16. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments. Pang SC Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025 [TBL] [Abstract][Full Text] [Related]
17. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Dahlgren J; Veimo D; Johansson L; Bech I Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rekaya N; Vicik SM; Hulesch BT; McDonald LL Rheumatol Ther; 2020 Sep; 7(3):537-552. PubMed ID: 32500508 [TBL] [Abstract][Full Text] [Related]
20. Epinephrine auto-injector needle lengths: Can both subcutaneous and periosteal/intraosseous injection be avoided? Dreborg S; Kim L; Tsai G; Kim H Ann Allergy Asthma Immunol; 2018 Jun; 120(6):648-653.e1. PubMed ID: 29499370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]